Ignite Creation Date:
2025-12-25 @ 1:39 AM
Ignite Modification Date:
2025-12-27 @ 10:47 PM
Study NCT ID:
NCT05022394
Status:
WITHDRAWN
Last Update Posted:
2022-05-27
First Post:
2020-04-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sapanisertib and Nivolumab for the Treatment of Stage I-IV Non-small Cell Lung Cancer in Patients Who Have Progressed on Prior PD-1/PD-L1 Inhibitor Therapy, I-OVERCOME Study
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-02-18
Start Date Type:
ACTUAL
Primary Completion Date:
2021-02-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-02-18
Completion Date Type:
ACTUAL
First Submit Date:
2020-04-22
First Submit QC Date:
None
Study First Post Date:
2021-08-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-24
Last Update Post Date:
2022-05-27
Last Update Post Date Type:
ACTUAL